BCP Partnering Portal / Fapon Biotech Inc
More Information on 'Fapon Biotech Inc'
Fapon Biotech Inc - Manufacturer based in Guangdong, China
Other Offices: China
About Fapon Biotech Inc
Fapon Biotech Inc. is a global leading IVD manufacturer which specialized in developing and producing high quality antigens and antibodies for diagnosis, as well as providing technical services in raw material application. Ever since Fapon was found, it has gone through ten years of independent research and development. Series of raw materials developed by Fapon have been widely used and recognized by customers from home and abroad for infectious, cardiovascular disease and tumor marker detection as well as food safty testing. Fapon is determined to continue focusing on the development of IVD raw materials and enriching our product line hence to provide our valued customers more high quality products and service in the future.see less
Industries:
Clinical / Diagnostics
Life Sciences
Products, Services & Applications:
Antibodies
Diagnostics
Diagnostics: Infectious Diseases
Immunology
Verified Member
The BCP Partnering Portal
Where Manufacturers and Channel Partners / Distributors find each other!
- The BCP Partnering Portal is a specialized matchmaking platform featuring over 27,000 company profiles, who supply products and services within scientific fields. It serves as a crucial resource for facilitating B2B partnerships between manufacturers and channel partners.
- Developed by BioChannel Partners Ltd, an award-winning B2B partnering company with over 21 years of expertise in connecting manufacturers and channel partners of scientific products, the portal ensures that company profiles are kept up-to-date by both the BCP team and verified profile owners.
- This continuous update process ensures that users have access to accurate and current information, enhancing the platform's effectiveness in fostering successful business collaborations.
- Take advantage of this resource and join to manage your own company profile and search for new partners.